Earnings
URGN
22.57
+7.27%
1.53
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
49.69M
97.39M
--
--
--
--
0.00
--
--
--
1.03M
523.00K
148.63M
4.71M
--
48.55M
--
--
--
--
487.00K
53.75M
202.39M
--
4.69M
0.00
--
--
--
--
--
14.79M
--
--
--
--
19.48M
0.00
--
--
--
2.60M
2.60M
22.09M
57.00K
407.99M
-228.02M
--
--
--
180.30M
180.30M
202.39M
FY 2018-12-31
101.32M
0.00
--
--
--
--
0.00
--
0.00
--
672.00K
253.00K
102.24M
948.00K
--
--
--
--
--
--
368.00K
1.32M
103.56M
--
4.27M
0.00
--
--
--
--
--
9.19M
--
--
--
0.00
13.46M
0.00
--
--
--
--
0.00
13.46M
44.00K
212.92M
-122.87M
--
--
--
90.09M
90.09M
103.56M
FY 2017-12-31
37.00M
36.00M
--
0.00
--
--
0.00
--
316.00K
--
958.00K
198.00K
74.47M
805.00K
--
--
--
--
--
--
273.00K
1.08M
75.55M
--
2.84M
0.00
--
--
--
4.43M
--
3.55M
--
--
--
650.00K
7.04M
0.00
--
--
--
--
0.00
7.04M
37.00K
115.69M
-47.21M
--
--
--
68.52M
68.52M
75.55M
FY 2016-12-31
21.36M
--
--
83.00K
--
--
0.00
--
105.00K
--
396.00K
95.00K
22.04M
741.00K
--
--
--
--
--
--
274.00K
1.01M
23.06M
--
--
0.00
--
--
--
1.88M
--
687.00K
--
--
--
570.00K
3.14M
3.61M
--
--
--
--
3.61M
6.75M
6000.00
43.50M
-27.21M
--
--
--
16.31M
16.31M
23.06M
FY 2015-12-31
17.98M
--
--
0.00
--
--
0.00
--
0.00
--
1.14M
21.00K
19.13M
259.00K
--
--
--
--
--
--
0.00
259.00K
19.39M
--
--
0.00
--
--
--
1.73M
--
509.00K
--
--
--
0.00
2.24M
872.00K
--
--
--
--
872.00K
3.11M
6000.00
41.53M
-25.27M
--
--
--
16.28M
16.28M
19.39M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out URGN latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Urogen Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.